State Street’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.6M Buy
1,972,523
+17,738
+0.9% +$239K ﹤0.01% 2066
2025
Q4
$22M Buy
1,954,785
+53,523
+3% +$612K ﹤0.01% 2216
2025
Q3
$22M Sell
1,901,262
-16,260
-0.8% -$190K ﹤0.01% 2191
2025
Q2
$23.5M Sell
1,917,522
-11,799
-0.6% -$148K ﹤0.01% 2102
2025
Q1
$27.6M Sell
1,929,321
-30,802
-2% -$481K ﹤0.01% 1949
2024
Q4
$31.2M Buy
1,960,123
+138,239
+8% +$2.74M ﹤0.01% 1961
2024
Q3
$43.8M Sell
1,821,884
-2,451
-0.1% -$56K ﹤0.01% 1767
2024
Q2
$36.3M Sell
1,824,335
-151,499
-8% -$2.95M ﹤0.01% 1822
2024
Q1
$39.3M Buy
1,975,834
+12,958
+0.7% +$250K ﹤0.01% 1850
2023
Q4
$44M Sell
1,962,876
-26,880
-1% -$555K ﹤0.01% 1775
2023
Q3
$40.2M Sell
1,989,756
-57,563
-3% -$1.3M ﹤0.01% 1759
2023
Q2
$52.3M Buy
2,047,319
+22,488
+1% +$592K ﹤0.01% 1647
2023
Q1
$60.2M Buy
2,024,831
+699
+0% +$20.3K ﹤0.01% 1522
2022
Q4
$54.8M Buy
2,024,132
+18,537
+0.9% +$453K ﹤0.01% 1564
2022
Q3
$43.7M Sell
2,005,595
-4,457
-0.2% -$116K ﹤0.01% 1684
2022
Q2
$55M Sell
2,010,052
-8,653
-0.4% -$249K ﹤0.01% 1578
2022
Q1
$67.6M Buy
2,018,705
+9,410
+0.5% +$303K ﹤0.01% 1572
2021
Q4
$69.7M Buy
2,009,295
+119,168
+6% +$3.85M ﹤0.01% 1576
2021
Q3
$59M Buy
1,890,127
+95,688
+5% +$3.25M ﹤0.01% 1687
2021
Q2
$65.3M Buy
1,794,439
+107,614
+6% +$4.45M ﹤0.01% 1651
2021
Q1
$73.8M Buy
1,686,825
+19,835
+1% +$931K ﹤0.01% 1462
2020
Q4
$76.5M Sell
1,666,990
-53,543
-3% -$2.23M ﹤0.01% 1357
2020
Q3
$57.2M Sell
1,720,533
-70,140
-4% -$2.24M ﹤0.01% 1356
2020
Q2
$52.6M Buy
1,790,673
+7,419
+0.4% +$215K ﹤0.01% 1436
2020
Q1
$48M Sell
1,783,254
-26,335
-1% -$786K ﹤0.01% 1277
2019
Q4
$61M Buy
1,809,589
+34,588
+2% +$1.25M ﹤0.01% 1377
2019
Q3
$66.5M Sell
1,775,001
-154,957
-8% -$5.91M 0.01% 1253
2019
Q2
$84.2M Buy
1,929,958
+3,342
+0.2% +$143K 0.01% 1164
2019
Q1
$82.2M Buy
1,926,616
+85,908
+5% +$3.85M 0.01% 1136
2018
Q4
$82.4M Sell
1,840,708
-50,335
-3% -$2.64M 0.01% 1019
2018
Q3
$130M Buy
1,891,043
+117,125
+7% +$7.54M 0.01% 906
2018
Q2
$102M Buy
1,773,918
+88,974
+5% +$4.7M 0.01% 1024
2018
Q1
$77.6M Sell
1,684,944
-19,600
-1% -$931K 0.01% 1146
2017
Q4
$78.7M Buy
1,704,544
+19,584
+1% +$900K 0.01% 1154
2017
Q3
$75.9M Sell
1,684,960
-17,463
-1% -$745K 0.01% 1135
2017
Q2
$66.9M Buy
1,702,423
+119,154
+8% +$4.5M 0.01% 1175
2017
Q1
$60.3M Buy
1,583,269
+28,718
+2% +$1.12M 0.01% 1215
2016
Q4
$57.5M Sell
1,554,551
-27,621
-2% -$987K 0.01% 1189
2016
Q3
$54.8M Buy
1,582,172
+59,316
+4% +$2.08M 0.01% 1182
2016
Q2
$49.5M Buy
1,522,856
+13,220
+0.9% +$405K 0.01% 1191
2016
Q1
$43.4M Sell
1,509,636
-25,994
-2% -$693K ﹤0.01% 1227
2015
Q4
$51.3M Buy
1,535,630
+8,710
+0.6% +$271K 0.01% 1170
2015
Q3
$43.4M Sell
1,526,920
-36,972
-2% -$1.29M 0.01% 1254
2015
Q2
$63.3M Buy
1,563,892
+198,589
+15% +$8.91M 0.01% 1123
2015
Q1
$67.2M Buy
1,365,303
+6,951
+0.5% +$322K 0.01% 1074
2014
Q4
$61.8M Buy
+1,358,352
New +$53.4M 0.01% 1110

Other funds holding AVNS